Ofyzone-S 1.5 Injection
Marketer
Medofy Pharmaceutical
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Ofyzone-S 1.5 Injection
Combiflox-S 1.5 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curtailing infection spread. Administration must be solely under a healthcare provider's guidance. Strictly adhere to the prescribed dosage schedule; complete the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek immediate medical assistance for allergic reactions (rash, pruritus, edema, dyspnea). Disclose all current medications to your physician prior to commencing treatment. Pregnant or lactating individuals require physician consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While usually non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and hydration are crucial for optimal recovery. Your physician may order lab work and diagnostic imaging to monitor treatment response.
Primary Ingredients of Ofyzone-S 1.5 Injection
The provided text is "undefined," offering no content to rephrase.
Uses of Ofyzone-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Ofyzone-S 1.5 Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Ofyzone-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ofyzone-S 1.5 Injection:
Administering this medication will be done by your physician or their qualified assistant; self-medication is strictly prohibited.
How Ofyzone-S 1.5 Injection works:
Ofyzone-S 1.5 Injection unites Ceftriaxone, a bacterial growth inhibitor, and Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their survival. Sulbactam augments Ceftriaxone's effectiveness by countering bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Ofyzone-S 1.5 Injection and alcohol poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The use of Ofyzone-S 1.5 Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Ofyzone-S 1.5 Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ofyzone-S 1.5 Injection might induce drowsiness, visual disturbances, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data on Ofyzone-S 1.5 Injection use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Administering Ofyzone-S 1.5 Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the Ofyzone-S 1.5 Injection dosage is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ofyzone-S 1.5 Injection :
Should you forget a dose of Ofyzone-S 1.5 Injection, seek your physician's advice.
Facts to Know About Ofyzone-S 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently